-
Vortrag
The impact of fremanezumab on symptoms associated with migraine in patients with chronic migraine
Speaker
Datum:
10.10.2019 ,
Zeit:
14:15
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details
-
Vortrag
Early Onset of Action with Fremanezumab versus Placebo for the Preventive Treatment of Chronic Migraine
Speaker
Datum:
10.10.2019 ,
Zeit:
14:21
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details
-
Vortrag
Early Onset of Action with Fremanezumab versus Placebo for the Preventive Treatment of Episodic Migraine
Speaker
Datum:
10.10.2019 ,
Zeit:
14:27
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details
-
Vortrag
Impact of Fremanezumab on the Number of Days with Use of Acute Headache Medications in Episodic Migraine
Speaker
Datum:
10.10.2019 ,
Zeit:
14:33
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details
-
Vortrag
Impact of Fremanezumab on the Number of Days With Use of Acute Headache Medications in Chronic Migraine
Speaker
Datum:
10.10.2019 ,
Zeit:
14:39
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details
-
Vortrag
Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of A 1-Year Study
Speaker
Datum:
10.10.2019 ,
Zeit:
14:45
|
Thema: 04. CGRP-Antikörper: Revolution der Kopfschmerztherapie?
Details